Bruker Co. (NASDAQ:BRKR) Declares Quarterly Dividend of $0.05

Bruker Co. (NASDAQ:BRKR) announced a quarterly dividend on Monday, February 24th, Wall Street Journal reports. Stockholders of record on Monday, March 17th will be paid a dividend of 0.05 per share by the medical research company on Friday, March 28th. This represents a $0.20 annualized dividend and a dividend yield of 0.39%. The ex-dividend date of this dividend is Monday, March 17th.

Bruker has increased its dividend payment by an average of 7.7% annually over the last three years. Bruker has a dividend payout ratio of 6.5% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Bruker to earn $3.15 per share next year, which means the company should continue to be able to cover its $0.20 annual dividend with an expected future payout ratio of 6.3%.

Bruker Price Performance

Shares of BRKR opened at $51.89 on Tuesday. Bruker has a fifty-two week low of $48.07 and a fifty-two week high of $94.86. The company has a 50 day moving average price of $56.63 and a 200-day moving average price of $59.95. The company has a debt-to-equity ratio of 1.15, a quick ratio of 0.77 and a current ratio of 1.60. The stock has a market capitalization of $7.87 billion, a PE ratio of 68.28, a PEG ratio of 2.16 and a beta of 1.16.

Bruker (NASDAQ:BRKR) last issued its quarterly earnings results on Thursday, February 13th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.75 by $0.01. Bruker had a net margin of 3.36% and a return on equity of 21.01%. Equities analysts predict that Bruker will post 2.69 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts recently commented on the stock. The Goldman Sachs Group upgraded shares of Bruker from a “sell” rating to a “neutral” rating and set a $60.00 price target on the stock in a research report on Thursday, December 5th. Wells Fargo & Company dropped their price target on shares of Bruker from $78.00 to $75.00 and set an “overweight” rating on the stock in a research report on Wednesday, November 6th. UBS Group assumed coverage on shares of Bruker in a research report on Tuesday, December 10th. They set a “neutral” rating and a $66.00 price target on the stock. Guggenheim restated a “buy” rating on shares of Bruker in a research report on Monday. Finally, Stifel Nicolaus dropped their price target on shares of Bruker from $70.00 to $57.00 and set a “hold” rating on the stock in a research report on Friday, February 14th. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $70.50.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.